Company: PIII
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001832511-25-000013
Chunk: 96

Company: P3 Health Partners Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 96
---
ical fees & insurance revenue1,800 0.3 3,052 0.4 Care coordination / management fees5,362 0.7 5,993 0.8 Incentive fees610 0.1 160 0.0 Total other patient service revenue7,772 1.1 9,205 1.2 Total revenue$729,013 100.0 %$767,645 100.0 %During each of the three months ended June 30, 2025 and 2024, four health plan customers each accounted for 10% or more of total revenue and collectively comprised 66% and 59% of the Company’s total revenue, respectively. During each of the six months ended June 30, 2025 and 2024, five and four health plan customers, respectively, each accounted for 10% or more of total revenue and collectively comprised 75% and 60% of the Company’s total revenue, respectively. Five and three health plan customers, respectively, each accounted for 10% or more of total health plan receivable as of June 30, 2025 and December 31, 2024, respectively.

Reverse Stock SplitOn April 11, 2025, the Company effected a 1-for-50 reverse stock split of its Class A common stock and Class V common stock, $0.0001 par value. All common stock amounts and references have been retroactively adjusted for all figures presented to reflect this split unless specifically stated otherwise. See Note 12 “Capitalization” included in this Form 10-Q for additional information related to the reverse stock split.

P3 Health Partners Inc. | Q2 2025 Form 10-Q | 12

Note 4: Recent Accounting PronouncementsRecent Accounting Pronouncements Not Yet AdoptedASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”)ASU 2024-03 enhances transparency and decision-usefulness of expense disclosures in response to investors’ requests for more detailed, disaggregated expense information, enabling a clearer understanding of a public business entity’s performance and cost structure. The amendments improve disclosure requirements in financial statement notes for specific expense categories, including inventory purchases, employee compensation, depreciation, amortization, and depletion, as well as qualitative descriptions of other expenses